The FDA Approves New HIV Pill

Share On Social!

The Food and Drug Administration (FDA) has approved a new once-a-day pill that combines four HIV drugs into one, NBC News reports.

This new medication could make life easier for the more than 200,000 Latinos living with HIV in the U.S.

“Genvoya contains a new form of tenofovir that has not been previously approved. This new form of tenofovir provides lower levels of drug in the bloodstream, but higher levels within the cells where HIV-1 replicates,” FDA said in a statement.

This new drug combines: emtricitabine, elvitegravir, cobicistat and tenofovir alafenamide.

According to the CDC, Latinos account for 23 percent of new HIV infections in the United States, but less than half are receiving medicines to treat their infection.

To learn more about HIV in the Latino community visit LatinoAids.